Results 221 to 230 of about 203,049 (341)

Pregnancy with a Left Ventricular Assist Device: A Narrative Review. [PDF]

open access: yesAnn Card Anaesth
Abraham MS   +6 more
europepmc   +1 more source

RELIABILITY TESTING OF IMPLANTABLE COMPONENTS FOR THE KANTROWITZ CARDIOVAD™ LEFT VENTRICULAR ASSIST DEVICE

open access: bronze, 1999
Renee P. Snyder   +4 more
openalex   +1 more source

Diagnosis and management of left ventricular assist device valve-endocarditis: LVAD valve replacement [PDF]

open access: bronze, 2000
Koen C de Jonge   +4 more
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Incidence, risk factors and clinical outcomes of pericardial effusion in left ventricular assist device patients. [PDF]

open access: yesWorld J Cardiol
Khan MZ   +12 more
europepmc   +1 more source

Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous‐flow left ventricular assist device

open access: yesEuropean Journal of Heart Failure, 2018
F. Consolo   +13 more
semanticscholar   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani   +11 more
wiley   +1 more source

Metabolic Reprogramming After Left Ventricular Assist Device

open access: yesJACC: Basic to Translational Science, 2016
J. Eduardo Rame, MD, MPhil   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy